VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BBIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BBIOBridgeBio Pharma, Inc.
$77.91$15.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBBIOQuarterly Cash Flow

BridgeBio Pharma, Inc. (BBIO) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

BridgeBio Pharma, Inc. (BBIO) quarterly cash flow statement — complete operating, investing & financing history

BBIO Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations-197.28M-56.42M-109.57M-80.68M-199.24M-195.33M-180.57M74.7M-219.54M-124.82M-145.23M-113.35M-144.32M-93.24M-135.16M-30.45M-160.63M-133.9M-121.56M-91.71M
Operating CF Margin %-101.42%-36.59%-90.78%-72.97%-170.82%-3320.74%-6609.3%3445.71%-103.99%-7152.95%-3549.89%-6907.56%-7903.72%-4986.26%-39989.05%-41.29%-9482.59%-1039.07%-5186.05%-169.76%
Operating CF Growth %0.98%71.11%39.32%-208%9.25%-56.49%-24.33%165.9%-52.12%-33.86%-7.45%-272.22%10.16%30.36%-11.19%66.8%-6.55%-39.1%7.69%-4.4%
Net Income-166.56M-190.26M-182.74M-183.76M-169.61M-267.39M-164.25M-73.46M-36.16M-170.33M-179.49M-160.7M-142.73M-140.57M-140.19M-2.56M-201.33M-152.28M-161.02M-96.35M
Depreciation & Amortization1.82M1.45M1.4M1.32M1.28M1.37M1.54M1.57M1.6M1.58M1.64M1.64M1.63M1.66M1.65M1.58M1.88M1.53M265K2.69M
Stock-Based Compensation33.24M34.64M037.24M25.88M30.13M27.16M21.45M17.06M37.02M22.6M27.18M21.91M21.79M17.36M28.29M24.12M19.77M16.04M0
Deferred Taxes00000000005.62M000000000
Other Non-Cash Items58.96M48.14M75.7M45.1M59.37M27.62M-42.87M-121.31M23.17M-15.08M3.09M4.97M6.67M12.13M-7.11M-91.04M24.76M-23.52M6.78M27.9M
Working Capital Changes-124.74M49.61M-3.93M19.42M-116.17M12.95M-2.14M246.44M-225.2M21.98M1.31M13.57M-31.8M11.75M-6.87M33.28M-10.07M20.6M16.37M-25.95M
Change in Receivables-65.78M-22.93M-39.65M38.4M-110.54M-4.24M182K234.83M-233.74M3.42M3.44M2.15M6.32M16M-3.83M-7.27M10.27M-11.58M37.19M-44.9M
Change in Inventory-7.05M-1.95M-6.77M-13.39M-3.19M00000-3.44M0003.83M00000
Change in Payables-7.17M17.52M-7.43M-1.05M17.57M-3.75M-3.6M14.79M-5.93M6.18M694K-298K-3.8M1.38M1.36M-1.28M-1.81M1.47M-11.66M11.23M
Cash from Investing-42.73M-13.75M4.46M-13M-1.59M-3.24M38.23M3.04M22.75M-66K37.68M4.12M12.3M17.96M146.86M149.7M138.62M21.8M58.97M-84.31M
Capital Expenditures-69K-33K-2.87M-594K-1.59M-47K-137K-54K-695K-435K-431K-428K-12K-801K-759K-2.4M-859K-2.54M-6.46M-2.29M
CapEx % of Revenue0.04%0.02%2.38%0.54%1.37%0.8%5.01%2.49%0.33%24.93%10.54%26.08%0.66%42.83%224.56%3.26%50.71%19.68%275.68%4.23%
Acquisitions0600K00000-98K00-38.11M0-503K0-147.62M0000-84.77M
Investments--------------------
Other Investing002.3M-4.5M0-3.19M-1.64M-2.39M24.89M038.11M000147.62M108.5M10M0-35M13.65M
Cash from Financing549.89M-2.78M-894K302.04M60.33M473.93M707K-5.73M279.55M-4.52M307.04M-1.23M150.25M6.38M1.45M-20.8M-160K325.38M-135.46M83.38M
Debt Issued (Net)608.41M-8.56M-5.89M300M116M500M0-3.73M-23.42M000000-20.49M0325.29M06.89M
Equity Issued (Net)-54.45M13.21M8.02M-2M-50.05M-1.4M-1.46M-2.24M312.32M-3.01M303.61M-170K142.5M5.98M-596K-366K-110K-2.25M-143.88M-3.84M
Dividends Paid00000000000000000000
Share Repurchases-82.5M00-2M-50.05M-1.4M-1.44M-1.74M-2.94M-2.56M-2.61M-1.2M-512K1.07M-596K-366K-110K-2.25M-143.88M-7.59M
Other Financing-4.07M-7.43M-3.02M4.04M-5.62M-24.66M2.17M241K-9.35M-1.51M3.44M-1.06M7.75M396K2.04M56K-50K2.35M8.43M80.32M
Net Change in Cash309.88M-72.41M-106.33M208.36M-140.5M275.37M-141.63M72.01M82.76M-129.41M199.5M-110.47M18.23M-68.9M13.14M98.45M-22.17M213.29M-198.05M-92.72M
Free Cash Flow-197.35M-60.95M-110.04M-85.78M-200.83M-198.56M-182.3M72.26M-221.03M-125.25M-145.66M-113.78M-144.33M-94.04M-135.92M-34.35M-161.49M-136.43M-163.02M-94M
FCF Margin %-101.46%-39.53%-91.17%-77.58%-172.19%-3375.77%-6672.69%3332.84%-104.69%-7177.88%-3560.43%-6933.64%-7904.38%-5029.09%-40213.61%-46.59%-9533.29%-1058.75%-6954.91%-174%
FCF Growth %1.73%69.3%39.64%-218.71%9.14%-58.53%-25.16%163.5%-53.14%-33.19%-7.16%-231.19%10.63%31.07%16.62%63.45%-5.74%-38.64%-23.28%-6.58%
FCF per Share-1.01-0.31-0.58-0.45-1.06-1.05-0.970.39-1.24-0.72-0.89-0.71-0.95-0.63-0.92-0.23-1.11-0.94-1.11-0.64
FCF Conversion (FCF/Net Income)1.20x0.29x0.60x0.44x1.19x0.74x1.11x-1.02x6.23x0.74x0.82x0.72x1.03x0.68x0.98x3.09x0.82x0.91x0.78x0.95x
Interest Paid000023.27M13.11M013.73M35.31M10.28M06.68M22.06M6.87M06.63M18.81M1.53M17.43M0
Taxes Paid00000000000000000000